Publication | Open Access

Three vs. 10 days of amoxycillin–clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study

Type 1Advanced Lung DiseaseMedicineDouble-blind StudyAmoxycillin–clavulanic AcidPulmonary MedicinePharmacologyPulmonary Disease